Latest editorial
Doses of AstraZeneca Covid-19 vaccine sit in a fridge at the vaccination centre
ASTRAZENECA must justify the “unequal” vaccine pricing it is offering countries, campaigners demanded today after the pharmaceutical giant revealed that its annual profits have more than doubled.
For 2020, the company reported pre-tax profits of $3.92 billion (£2.83bn) due to the success of new medicines.
The profits haul marks a significant rise on the $1.55bn (£1.12bn) seen in 2019.
CLAUDIA WEBBE says the horrific price British patients will pay for this NHS deal is now clear — and there’s time to get out of it, if MPs will only force the issue
The US blockade of Cuba raises risks of a new global pandemic, experts warn at Unison conference
Politicians who continue to welcome contracts with US companies without considering the risks and consequences of total dependency in the years to come are undermining the raison d’etre of the NHS, argues Dr JOHN PUNTIS